Methods for medical imaging
OwnerSunil Singhalinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to methods of identifying, detecting, and locating a tissue(s), nodule(s) or mass(es) and its draining lymph nodes that is/are suspected to be abnormal, typically a neoplasm (i.e., cancer, malignancy, premalignancy) in an individual undergoing an invasive procedure (i.e., surgery or endoscopy) or a non-invasive procedure (ie. radiology). The method involves the use of, for example, indocyanine green (ICG). The uptake of this dye is different by diseased tissues and lymph nodes compared to non-diseased tissues when administered at the appropriate combination of dose and time and monitored with an appropriate device that can excite and capture the signal.
Claims27
A method for identifying abnormal tissue in a subject during an operative, radiologic or endoscopic procedure, said method comprising:
- (a) administering to the subject a fluorophore preparation comprising an effective amount of at least one fluorophore, wherein said at least one fluorophore comprises indocyanine green (ICG) in a total systemic dose of at least about 2 mg/kg of body weight of the subject, wherein the administration is systemic;
- (b) conducting said procedure after a waiting period subsequent to said administration, wherein said waiting period is selected from the group consisting of at least about 12 hours, about 24 hours, about 36 hours, about 48 hours, between about 12 to about 24 hours, between about 24 to about 36 hours, between about 36 to about 48 hours;
- (c) during the procedure, illuminating the area of interest with an illumination source emitting electromagnetic radiation (emr) having at least one wavelength which interacts with ICG dye, the emr having a wavelength of from about 600 nm to about 1000 nm;
- (d) imaging the abnormal tissue with an imaging device, wherein the abnormal tissue displays significantly more fluorescence caused by the fluorophore preparation;
- (e) optionally imaging the lymph nodes draining from the abnormal tissue;
- (f) optionally, treating sites of abnormal tissue by external beam radiation, laser therapy, or surgical removal.
A kit comprising a vial containing a sterile preparation of a fluorophore preparation for systemic administration comprising an effective amount of at least one fluorophore, wherein said at least one fluorophore comprises indocyanin green (ICG), and instructions for use, wherein said instructions direct administration of ICG at a total systemic dose of at least about 2 to 5 mg/kg of body weight of the subject, but up to 10 mg/kg, and direct a waiting period after administration of the fluorophore preparation is selected from the group consisting of about 12 hours, about 24 hours, about 36 hours, about 48 hours, between about 12 to about 24 hours, between about 24 to about 36 hours, between about 36 to about 48 hours.
A method for identifying abnormal tissue in a subject during an operative or endoscopic procedure, said method comprising:
- (a) administering to the subject a fluorophore preparation comprising an effective amount of at least one fluorophore, wherein said at least one fluorophore comprises indocyanin green (ICG), wherein the administration is systemic, further wherein the ICG is administered in a total systemic dose of about 2 to 10 mg/kg of body weight of the subject;
- (b) conducting said procedure after a waiting period subsequent to said administration, wherein said waiting period is at least about 12 hours;
- (c) during the procedure, illuminating the area of interest with an illumination source emitting electromagnetic radiation (emr) having at least one wavelength which interacts with ICG dye, the emr having a wavelength of from about 600 nm to about 1000 nm;
- (d) imaging the abnormal tissue, optionally with an imaging device, wherein the abnormal tissue displays significantly more fluorescence caused by the fluorophore preparation;
- (e) optionally imaging the lymph nodes draining from the abnormal tissue;
- (f) optionally, treating sites of abnormal tissue by external beam radiation, laser therapy, or surgical removal.
A method for identifying abnormal tissue in a subject during an operative or endoscopic procedure, said method comprising:
- (a) administering to the subject a fluorophore preparation comprising an effective amount of at least one fluorophore, wherein said at least one fluorophore comprises indocyanine green (ICG), wherein the administration is systemic, further wherein the ICG is administered in a total systemic dose of at least about 2 to about 5 mg/kg of body weight of the subject, but up to 10 mg/kg;
- (b) conducting said procedure after a waiting period subsequent to said administration, wherein said waiting period is at least about 24 hours;
- (c) during the procedure, illuminating the area of interest with an illumination source emitting electromagnetic radiation (emr) having at least one wavelength which interacts with ICG dye, the emr having a wavelength of from about 600 nm to about 1000 nm;
- (d) imaging the abnormal tissue, optionally with an imaging device, wherein the abnormal tissue displays significantly more fluorescence caused by the fluorophore preparation;
- (e) optionally imaging the lymph nodes draining from the abnormal tissue;
- (f) optionally, treating sites of abnormal tissue by external beam radiation, laser therapy, or surgical removal.
Dependencies are inferred from the claim text.